𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term Outcome of Diffuse Proliferative Lupus Glomerulonephritis Treated with Cyclophosphamide

✍ Scribed by Chi Chiu Mok; King Yee Ying; Woon Leung Ng; Ka Wing Lee; Chi Hung To; Chak Sing Lau; Raymond Woon Sing Wong; Tak Cheung Au

Book ID
116210896
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
147 KB
Volume
119
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predictors and outcome of renal flares a
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis
✍ Chi Chiu Mok; King Yee Ying; Sydney Tang; Chung Ying Leung; Ka Wing Lee; Woon Le πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 1 views

## Abstract ## Objective To study the incidence, predictors, and outcome of renal flares after successful cyclophosphamide (CYC) treatment for diffuse proliferative glomerulonephritis (DPGN) in patients with systemic lupus erythematosus (SLE). ## Methods Between 1988 and 2001, patients with biop

Histopathologic and clinical outcome of
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
✍ Iva Gunnarsson; Birgitta Sundelin; Thorunn JΓ³nsdΓ³ttir; Stefan H. Jacobson; Elisa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell–dependent diseases, including systemic lupus erythematosus (SLE). The purpose